United States Biomarker Discovery Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Abcam Limited, Olink, SomaLogic and BD

Biomarker Discovery Market reached US$ 17.84 billion in 2023, rising to US$ 19.80 billion in 2024, and is projected to reach US$ 54.19 billion by 2033, growing at a CAGR of 11.9% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Biomarker Discovery Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/biomarker-discovery-market?sg

Key Players: Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Merck KGaA, Hoffmann-La Roche Ltd, Abcam Limited, Olink, SomaLogic and BD.

USA - Industry Latest News:
✅ Jun 23, 2025 - Illumina announced agreement to acquire SomaLogic to accelerate its proteomics/multi-omics capabilities.
✅ Jul 08, 2025 - Quanterix completed its acquisition of Akoya Biosciences, creating an integrated blood-and-tissue biomarker platform.

Japan - Industry Latest News:
✅ May 26, 2025 - Illumina's comprehensive genomic profiling test received regulatory approval in Japan, expanding precision-oncology access.
✅ Sep 01, 2025 - Otsuka opened a new Tokyo laboratory to strengthen biomarker and digital-biomarker research capability in Japan.

Korea - Industry Latest News:
✅ Jun 01, 2025 - Seer and Korea University launched a large-scale Proteograph study to identify early-onset cancer blood biomarkers using mass-spec + AI.
✅ Jun 16, 2025 - Samsung Biologics launched "Samsung Organoids" drug-screening services to support precision screening and biomarker-driven development.

Europe - Industry Latest News:
✅ May 21, 2025 - Sanofi agreed to acquire Vigil Neuroscience (≈$470M) to bolster its neurology pipeline (strategic M&A).
✅ Jan 09, 2025 - UK Biobank Pharma Proteomics Project selected Olink's Explore HT (Thermo Fisher) to profile ~5,400 proteins across up to 600,000 samples - a major European-based proteomics initiative for biomarker discovery.

Key Development:

✅ Jun 01, 2025 - Seer's Proteograph enables a 20,000-sample proteomics study with Korea University.
Study aims to identify blood biomarkers for early-onset cancers using large-scale proteomics + AI.

✅ May 29, 2025 - Seer launches a next-generation Proteograph workflow at ASMS 2025.
New workflow promises greater scale and efficiency for deep, unbiased proteomics studies.

Growth Forecast Projected:

The Global Biomarker Discovery Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Biomarker Discovery Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=biomarker-discovery-market?sg

Key Segments:

By Product Type (Consumables, Instruments, Software)

By Technology (Genomics, Proteomics, Metabolomics, Transcriptomics, Epigenomics, Lipidomics and Others)

By Application (Drug Discovery, Diagnostics, Personalized Medicine and Others)

By End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, Diagnostic Labs, Hospitals and Others)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Biomarker Discovery producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Biomarker Discovery revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/biomarker-discovery-market?sg

FAQ's

Q1: What is the current size of the Biomarker Discovery Market?

A: The Biomarker Discovery Market stood at US$ 19.80 billion in 2024 and is set to experience remarkable growth, reaching US$ 54.19 billion by 2033

Q2: How fast is the Biomarker Discovery Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 11.9% from 2025-2033

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/biomarker-discovery-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.